Delivery Order SPE2DE21D7010-SPE2D626F06H4
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $22,128.07 on November 25, 2025, for the supply of MODULUS spinal surgical products and related medical devices. This fixed-price contract with economic price adjustment mechanisms is scheduled for completion by January 2, 2026, with performance conducted at Nuvasive's San Diego, California facility. The contract was issued without set-aside...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $11,287.94 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. The contract, designated as Delivery Order 4570101607, involves the procurement of MODULUS spinal surgical products and is structured as a fixed-price agreement with economic price adjustment provisions to accommodate cost fluctuations in specialized medical device...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and services, has been awarded a delivery order valued at $22,408.89 by the Defense Logistics Agency (DLA) Medical Supply Chain on September 22, 2025. The contract, which carries no set-aside designation, is for the delivery of MODULUS spinal medical products and is structured as a fixed-price agreement with economic price adjustment provisions. Performance is scheduled to conclude by October...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $20,821.36 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency Medical Supply Chain on October 23, 2025. The delivery order, designated as Contract No. 4569849710 for MODULUS spinal surgical products, carries an ultimate completion date of November 18, 2025, and will be performed at Nuvasive's San Diego, California facility. This award...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order contract valued at $7,358.52 by the Defense Logistics Agency Medical Supply Chain on October 23, 2025, with a completion date of October 24, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment mechanisms and covers the supply of the MODULUS spinal surgical product to support federal healthcare operations. This award...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and implants, was awarded a $11,287.94 fixed-price delivery order (Contract 4569593362) by the Defense Logistics Agency (DLA) Medical Supply Chain on September 22, 2025. The delivery order, which includes economic price adjustment provisions, is designated for the MODULUS product line and has an ultimate completion date of September 23, 2025. The contract was awarded without set-aside...
- Nuvasive, Inc. was awarded a $11,287.94 fixed-price delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain for the MODULUS spinal medical device on September 11, 2025, with completion scheduled for September 12, 2025. The contract, which carries no set-aside designation, reflects Nuvasive's competitive position in open market procurements for specialized spinal medical technologies. The place of performance is located in San Diego, California, where Nuvasive maintains its...
- Nuvasive, Inc. was awarded a $21,057.10 fixed-price delivery order with economic price adjustment on April 24, 2025, by the Defense Logistics Agency (DLA) Medical Supply Chain for the MODULUS spinal medical product line. The contract specifies a place of performance in San Diego, California, with an ultimate completion date of April 25, 2025. This delivery order carries no set-aside designation, indicating the award resulted from open market competition. Nuvasive, a subsidiary of Transplant...
- On September 15, 2025, the Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order contract valued at $12,969.81 to Nuvasive, Inc. for the provision of MODULUS spinal medical devices. The contract, which carries no set-aside designation, represents a fixed-price delivery order with economic price adjustment pricing mechanisms and is scheduled for completion by October 3, 2025. Performance will take place at Nuvasive's facility in San Diego, California. This delivery order...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $5,204.05 on November 14, 2025, by the Defense Logistics Agency Medical Supply Chain. This fixed-price delivery order with economic price adjustment provisions is for the supply of LEVERAGE LFS spinal medical devices and related surgical instruments, with performance to be completed by December 5, 2025, at Nuvasive's...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F06H4Delivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $5,477.02 on December 4, 2025, for the MODULUS spinal surgical product through the Defense Logistics Agency (DLA) Medical Supply Chain. This fixed-price contract with economic price adjustment provisions is scheduled for completion by December 31, 2025, with performance occurring at Nuvasive's San Diego facility. The award carries no set-aside designation, reflecting Nuvasive's successful competition in open market federal procurements serving Department of Defense and Department of Veterans Affairs healthcare facilities. This delivery order is issued under the broader $8 million Blanket Purchase Agreement (BPA) between Transplant Technology Inc. and the Defense Health Agency, structured as an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle effective through March 2027. The BPA framework enables streamlined procurement of Nuvasive's comprehensive portfolio of spinal fusion devices, implants, surgical instruments, and biologics across military and veteran healthcare networks nationwide. Nuvasive has established itself as a critical supplier of specialized orthopedic and neurosurgical technologies supporting advanced surgical capabilities across the federal healthcare enterprise, with the MODULUS product representing one component of its extensive offerings in spinal medical device solutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 12/3/25 |